Table 1.
Correlation of the CRP/Alb ratio with the clinicopathological characteristics of patients
| Variable | No. of Patients (%) | |||
|---|---|---|---|---|
|
|
P value | |||
| CRP/Alb ratio | ||||
|
| ||||
| <0.060 (n=163) | 0.060-0.115 (n=150) | ≥0.115 (n=93) | ||
| Age (years) | 0.007* | |||
| <57.5 | 91 (22.4) | 75 (18.5) | 33 (8.1) | |
| ≥57.5 | 72 (17.7) | 75 (18.5) | 60 (14.8) | |
| Sex | 0.221 | |||
| Male | 99 (24.4) | 89 (21.9) | 65 (16.0) | |
| Female | 64 (15.8) | 61 (15.0) | 28 (6.9) | |
| T stage | <0.001* | |||
| 1 | 144 (35.5) | 135 (33.3) | 61 (15.0) | |
| 2 | 15 (3.7) | 11 (2.7) | 13 (3.2) | |
| 3 | 4 (1.0) | 4 (1.0) | 18 (4.4) | |
| 4 | 0 (0.0) | 0 (0.0) | 1 (0.2) | |
| N stage | 0.163 | |||
| 0 | 159 (39.1) | 148 (36.5) | 88 (21.7) | |
| 1 | 4 (1.0) | 2 (0.5) | 5 (1.2) | |
| M stage | 0.034* | |||
| 0 | 163 (40.1) | 150 (37.0) | 91 (22.4) | |
| 1 | 0 (0.0) | 0 (0.0) | 2 (0.0) | |
| TNM stage | <0.001* | |||
| I | 142 (35.0) | 134 (33.0) | 59 (14.5) | |
| II | 15 (3.7) | 11 (2.7) | 12 (3.0) | |
| III | 6 (1.5) | 5 (1.2) | 19 (4.7) | |
| IV | 0 (0.0) | 0 (0.0) | 3 (0.7) | |
| Tumor necrosis | <0.001* | |||
| Absent | 155 (38.2) | 142 (35.0) | 71 (17.5) | |
| Present | 8 (2.0) | 8 (2.0) | 22 (5.4) | |
| Lymphovascular invasion | <0.001* | |||
| Absent | 160 (39.4) | 146 (36.0) | 80 (19.7) | |
| Present | 3 (0.7) | 4 (1.0) | 13 (3.2) | |
| Hemoglobin (g/L) | <0.001* | |||
| <116.05 | 14 (3.4) | 13 (3.2) | 30 (7.4) | |
| ≥116.05 | 149 (36.7) | 137 (33.7) | 63 (15.5) | |
| Ca (mmol/L) | 0.005* | |||
| <2.40 | 71 (17.5) | 73 (18.0) | 59 (14.5) | |
| ≥2.40 | 91 (22.4) | 75 (18.5) | 32 (7.9) | |
*
indicates that the difference was statistically significant.
Abbreviation: TNM tumor-node-metastasis, CRP/Alb the C-reactive protein/Albumin ratio, Ca calcium.